Some measures of success continued to improve in men with type 2 diabetes on testosterone replacement therapy. Others reverted to the norm of the placebo group. The abstract says:
"Improvement in HbA1c and weight at the end of the RCT [randomized clinical trial] and open-label phase in men on...